Tag Archives: metastatic bladder cancer

March, 2016

  • 3 March

    FDA Approves New Indication for AstraZeneca’s Faslodex

    AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved a new indication expanding the use of FASLODEX® (fulvestrant) to include use in combination with palbociclib. The combination use is for the treatment of women with hormone receptor-positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) …

February, 2015